Notice: Constant automattic\jetpack\extensions\social_previews\FEATURE_NAME already defined in /home2/theprkho/public_html/thepharmatimes.in/wp-content/plugins/jetpack/extensions/blocks/social-previews/social-previews.php on line 14
Premas Lifesciences Announces Partnership With Leading Secondary Analysis Provider Edico Genome - The Pharma Times | Pharma & Health Care News Portal
Archives

Premas Lifesciences Announces Partnership With Leading Secondary Analysis Provider Edico Genome

Brings Ultra-Rapid Next Generation Sequencing Data Analysis with DRAGEN Bio-IT Platform in India

New Delhi, April 27, 2018: Premas Life Sciences and Edico Genome today announced a new sales distribution agreement, appointing Premas Life Sciences as the sole distributor of Edico Genome’s DRAGEN Bio-IT Platform in India. DRAGEN delivers industry leading speed and accuracy, earning top marks for its accuracy in the latest PrecisionFDA Challenge and two Guinness World Records™ for its speed.

Through this partnership, Premas Life Sciences will bring Edico Genome’s best-in-class DRAGEN Bio-IT Platform and comprehensive suite of DRAGEN pipelines to life science organizations throughout India.

“We are proud of our association as the sole distributor for the leading secondary analysis solution provider for next-generation sequencing (NGS),” said Praveen Gupta, Managing Director of Premas Life Sciences. “Genome Centers and Researchers in India will greatly benefit from the flexibility, speed and accuracy that the DRAGEN platform delivers for their projects.”

Leveraging field-programmable gate array (FPGA) technology, DRAGENcan process an entire human genome at 30x coverage in 20 minutes, as compared to over 20 hours using traditional CPU based message.The DRAGEN platform offers accuracy, speed and scalability allowing customers of all sizes to emphasize on what is most significant– delivering breakthrough results. The all-inclusive set of DRAGEN pipelines can be run onsite, in the Cloud or through a seamless hybrid cloud blend, facilitating organizations to scale as their throughput fluctuates.

“As life science organizations across the globe continue to generate an ever-growing abundance of genomic data, the need for scalable, cost effective and, most importantly, rapid secondary analysis pipelines continue to grow in-step,” said Katherine Atkinson, VP of Business Development at Edico Genome. “Through our partnerships with world-class sales distributors, including Premas Life Sciences, our innovative technology can now reach all corners of the globe. Premas Life Sciences has an outstanding track record, and we look forward to cultivating our presence in India with Premas Life Sciences as our partner.”

For more information about DRAGEN’s suite of pipelines, visit http://edicogenome.com/pipelines/

Did you know? 

  • DRAGEN is the World’s Fastest, Secondary Analysis Solution
  • DRAGEN platform solves two key problems in big data genomics: lengthy compute times and massive amounts of data.
  • To date, DRAGEN has processed more than 1,000,000 customer samples
  • DRAGEN is utilized by leading sequencing centers, labs, and hospitals around the world.

Corporate Comm India(CCI Newswire)

The Pharma Times News Bureau

Recent Posts

Fortis Hospital, Bannerghatta Road Launches dedicated Parkinson’s Disease and Deep Brain Stimulation Clinic

-  This specialized division empowers patients with neurological disorders to reclaim their mobility through a…

3 days ago

Milestone set in Indian Medical History – SSI Mantra Surgical Robotic System Performs the First-Ever Successful Surgery on One-Year-Old Infant

SSI Mantra Robotic System performs a successful urology procedure on a one-year-old infant with a…

5 days ago

Manipal Hospital Ghaziabad organises Fire Safety Training to Enhance Emergency Response

Ghaziabad, April 22, 2024: In order to strengthen the safety and wellbeing of people, Manipal Hospital…

2 weeks ago

Professor Dr Robert Zeiser receives DKMS Mechtild Harf Science Award 2024

DKMS EMPHASIZES ITS COMMITMENT TO BLOOD CANCER RESEARCH, SUPPORTS YOUNG SCIENTISTS, AND RECOGNIZES OUTSTANDING RESEARCH…

2 weeks ago

Dr. Reddy’s launches drug-free migraine management device Nerivio® in Europe following successful launch in India

Dr. Reddy's has launched Nerivio® in Germany through its step-down subsidiary betapharm To be followed…

3 weeks ago

Ankura Hospital Doctors perform a successful Complex Lung Surgery on a 4-month-old Infant

 Hyderabad, April 13, 2024: Ankura Hospital for Women and Children is proud to announce a remarkable medical…

3 weeks ago